Search

everythinglearnresearchcommunity

for

Search:↓

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

A patient's skin eruption was caused by the cancer drug cyclophosphamide and improved after stopping the drug.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Non-ablative fractional laser treatments have a low risk of side effects in Asian patients.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

EGFR inhibitors can cause yellowish skin eruptions.

Some cases of folliculotropic mycosis fungoides may progress slowly and not need aggressive treatment.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Isotretinoin effectively treated severe acne in HIV-positive women, with improved skin and CD4 counts, but some experienced side effects like skin dryness and hair loss.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.

A 21-year-old had a rare developmental anomaly with a misplaced sebaceous gland in a hair follicle.

Mexican patients had a lower incidence of skin reactions to drugs and no significant link between these reactions and the TNF2 gene variant.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

The case suggests a possible link between severe acne and certain bone deformities.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Cetuximab can cause excessive eyelash growth.

Some immunosuppressed patients can get unusual skin infections from Malassezia, which can be treated with antifungal medication.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Panitumumab can cause excessive ear hair growth.

Understanding drug interactions, side effects, and patient-specific factors is crucial for effective dermatological care.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

Targeted cancer therapies often cause serious skin problems that need careful management.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Clobetasol propionate ointment can help some people with total hair loss regrow hair.

Ablative fractional resurfacing could improve how well topical drugs penetrate the skin, but more research is needed to fine-tune the method.